Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Clinical trial NCT02807636 · COMPLETED
Trial details
- NCT number
- NCT02807636
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-30
- Primary completion
- 2022-08-31
- Enrollment
- 1213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.